Valeant Pharmaceuticals
Recent activities involving Valeant Pharmaceuticals announced
Published in Health Business Week, November 24th, 2006
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Valeant Pharmaceuticals.
Report 1: Valeant Pharmaceuticals International (VRX) announced that the Securities and Exchange Commission is conducting an informal inquiry regarding events and circumstances surrounding trading in the company's common stock and the public release of data from its first pivotal phase 3 trial for Viramidine.
In addition, the SEC requested data regarding the company's stock option grants since January 1, 2000 and information about the company's...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2006-11-24)
More Articles from Health Business Week
- Abdominal Aortic Aneurysms
Endologix announces favorable Powerlink five-year follow-up data at TCT 2006 Conference - Acute Myeloid Leukemia
Lorus presents GTI-2040 pharmacokinetic and metabolic data in acute myeloid leukemia - Allergy & Immunology
Altana Pharma receives approval to market Ciclesonide nasal spray in the U.S. - Allergy & Immunology
SAFC appointed by Curalogic to provide chemical development services - Antibacterial Agents
Pneumonia germ cell wall can damage heart, brain cells - Antibacterial Agents
U.S. Food and Drug Administration issues non-approvable letter to Replidyne for faropenem - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
